ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wright, C. D.
Right arrow Articles by Logan, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wright, C. D.
Right arrow Articles by Logan, D. L.

The Annals of Thoracic Surgery, Vol 58, 1574-1578, Copyright © 1994 by The Society of Thoracic Surgeons


ARTICLES

Evolution of treatment strategies for adenocarcinoma of the esophagus and gastroesophageal junction

CD Wright, DJ Mathisen, JC Wain, HC Grillo, AD Hilgenberg, AC Moncure, RW Carey, NC Choi, M Daly and DL Logan
General Thoracic Surgical Unit, Massachusetts General Hospital, Boston 02114.

Between 1980 and 1988, 91 patients with adenocarcinoma of the esophagus were treated by surgical resection and selective postoperative therapy. Operative mortality was 2%. Pathologic stage was I in 4, II in 26, and III in 61. Actuarial 2- and 5-year survival was 24% and 8%. From 1987 to 1989, 16 patients with adenocarcinoma of the esophagus were treated with two cycles of 5-fluorouracil and cisplatin followed by surgical resection. There was 1 complete response (6%), 5 partial responses (31%), and 10 with no response (63%). Twelve patients had resection. Pathologic stage was I in 1, II in 4, and III in 8. There was one chemotherapy-related death and one surgical death. Actuarial 4-year survival is 42%. From 1990 to 1993, 22 patients with adenocarcinoma of the esophagus were treated with two cycles of etoposide, doxorubicin, and cisplatin followed by surgical resection. There was 1 complete response (5%), 11 partial responses (50%), and 10 with no response (45%). Eighteen patients had resection. Pathologic stage was 0 in 1, II in 8, and III in 9. There were no treatment-related deaths. The actuarial 2-year survival is 58%. Conclusions are necessarily limited because the patients were not treated in a randomized fashion. These preliminary results with preoperative chemotherapy appear improved (p = 0.04 and p = 0.004, respectively) as compared with results from 1980 to 1988 without preoperative chemotherapy.


This article has been cited by other articles:


Home page
JNMHome page
P. A.M. Heeren, P. L. Jager, F. Bongaerts, H. van Dullemen, W. Sluiter, and J. Th.M. Plukker
Detection of Distant Metastases in Esophageal Cancer with 18F-FDG PET
J. Nucl. Med., June 1, 2004; 45(6): 980 - 987.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
H. Igaki, H. Kato, Y. Tachimori, H. Sato, H. Daiko, and Y. Nakanishi
Prognostic evaluation for squamous cell carcinomas of the lower thoracic esophagus treated with three-field lymph node dissection
Eur. J. Cardiothorac. Surg., June 1, 2001; 19(6): 887 - 893.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
C. van de Ven, P. De Leyn, W. Coosemans, D. Van Raemdonck, and T. Lerut
Three-field lymphadenectomy and pattern of lymph node spread in T3 adenocarcinoma of the distal esophagus and the gastro-esophageal junction
Eur. J. Cardiothorac. Surg., June 1, 1999; 15(6): 769 - 773.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
C. D. Wright, J. C. Wain, T. J. Lynch, N. C. Choi, M. L. Grossbard, R. W. Carey, A. C. Moncure, H. C. Grillo, and D. J. Mathisen
INDUCTION THERAPY FOR ESOPHAGEAL CANCER WITH PACLITAXEL AND HYPERFRACTIONATED RADIOTHERAPY: A PHASE I AND II STUDY
J. Thorac. Cardiovasc. Surg., November 1, 1997; 114(5): 811 - 816.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
W. H. Steup, P. De Leyn, G. Deneffe, D. Van Raemdonck, W. Coosemans, and T. Lerut
TUMORS OF THE ESOPHAGOGASTRIC JUNCTIONLong-term survival in relation to the pattern of lymph node metastasis and a critical analysis of the accuracy or inaccuracy of pTNM classification
J. Thorac. Cardiovasc. Surg., January 1, 1996; 111(1): 85 - 95.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1994 by The Society of Thoracic Surgeons.